The Safety and Efficacy of Certolizumab Pegol in Rheumatoid Arthritis used in Routine Canadian Clinical Practice: Interim Analysis of the FasT CAN Study

Shaikh Saeed; Bessette Louis; Bensen William; Chow Andrew; Dixit Sanjay; Haraoui Boulos; Syrotuik Jerry

首页> 外文期刊>The Journal of rheumatology >The Safety and Efficacy of Certolizumab Pegol in Rheumatoid Arthritis used in Routine Canadian Clinical Practice: Interim Analysis of the FasT CAN Study

【24h】

The Safety and Efficacy of Certolizumab Pegol in Rheumatoid Arthritis used in Routine Canadian Clinical Practice: Interim Analysis of the FasT CAN Study

机译：Certolizumab Pegol在类风湿关节炎中的安全性和有效性在加拿大的常规临床实践中使用：FasT CAN研究的中期分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of rheumatology》 |2015年第7期|共1页
作者
Shaikh Saeed; Bessette Louis; Bensen William; Chow Andrew; Dixit Sanjay; Haraoui Boulos; Syrotuik Jerry;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. The Safety and Efficacy of Certolizumab Pegol in Rheumatoid Arthritis used in Routine Canadian Clinical Practice: Interim Analysis of the FasT CAN Study [J] . Shaikh Saeed, Bessette Louis, Bensen William, The Journal of rheumatology . 2015,第7期

机译：Certolizumab Pegol在类风湿关节炎中的安全性和有效性在加拿大的常规临床实践中使用：FasT CAN研究的中期分析
2. Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study [J] . Louis Bessette, Boulos Haraoui, Andrew Chow, Therapeutic advances in musculoskeletal disease. . 2019,第12期

机译：Cartolizumab Pegol在加拿大实践中的类风湿性关节炎患者的有效性和安全性：观察性Fαst-CAN的2年结果
3. The Effectiveness and Safety of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study [J] . Bessette Louis, Haraoui Boulos, Chow Andrew, The Journal of rheumatology . 2018,第7期

机译：Certolizumab PEGOL在加拿大实践环境中的类风湿性关节炎患者的有效性和安全性：非介入F-alphast的两年结果可以研究
4. IMANI-1 TC3WP Single Drug HAART -Proof of Concept Study Pilot Study of the Safety and Efficacy of Kaletra (LPV/r) as Single Drug HAART in HIV+ ARV- Naive Patients - Interim Analysis of Subjects Completing Final 48 Week Data [C] . J.C. Gathe Jr., M. Washington, C. Mayberry International AIDS Conference . 2004

机译：Imani-1 TC3WP单药搭载概念研究试验试验研究Kaletra（LPV / R）作为艾滋病毒+ ARV天真患者单药HAART的安全性和有效性 - 临时分析受试者完成最终的48周数据
5. Clinical research on the preventive efficacy of sulfasalazine against Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis [D] . 布川貴博 2019

机译：柳氮磺胺吡啶对类风湿关节炎肺炎克氏杆菌的预防作用的临床研究
6. Extended report: Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study [O] . R Fleischmann, J Vencovsky, R F van Vollenhoven, -1

机译：扩展报告：类风湿关节炎患者先前失败的抗风湿疗法治疗失败后每4周使用certolizumab聚乙二醇单药治疗的有效性和安全性：FAST4WARD研究
7. Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study [O] . Fleischmann, R, Vencovsky, J, van Vollenhoven, R F, 2008

机译：FAST4WARD研究表明，风湿性关节炎患者每4周使用一次certolizumab聚乙二醇单药治疗的有效性和安全性

The Safety and Efficacy of Certolizumab Pegol in Rheumatoid Arthritis used in Routine Canadian Clinical Practice: Interim Analysis of the FasT CAN Study

著录项

相似文献

相关主题

期刊订阅